Azenta Inc
(NAS:AZTA)
$
51.3
-0.27 (-0.52%)
Market Cap: 2.34 Bil
Enterprise Value: 1.94 Bil
PE Ratio: 0
PB Ratio: 1.32
GF Score: 73/100 Azenta Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 11, 2022 / 11:00PM GMT
Release Date Price:
$61.56
(-0.55%)
Elizabeth Cristina Mari Garcia
UBS Investment Bank, Research Division - US Life Science Analyst
Hello. Welcome. We saved the best for last. I am here to welcome -- you've got Liza Garcia again, UBS life science analyst -- life sciences and tools. So I am here with Lindon Robertson, the CFO of Azenta. We are fortunate enough to have him join us, and he will be doing a presentation first that he will begin, and then we will move into a fireside chat.
So with that, Lindon, I will let you roll with it.
Lindon G. Robertson
Azenta, Inc. - Executive VP & CFO
Thanks, Liza.
Elizabeth Cristina Mari Garcia
UBS Investment Bank, Research Division - US Life Science Analyst
All right.
Lindon G. Robertson
Azenta, Inc. - Executive VP & CFO
So thank you for all the attention and interest in Azenta today. I'll go right into the charts and save some time for some discussion with Liza, and there we go. Let me go back.
So we do hit the safe harbor statement.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot